[Pulmonary function tests in chronic obstructive pulmonary disease].

Area of Science:

• Pulmonology
• Respiratory Medicine
• Diagnostic Imaging

Context:

• Chronic obstructive pulmonary disease (COPD) diagnosis requires assessing irreversible airflow limitation.
• Severity staging is crucial for patient management and follow-up.
• Pulmonary function tests are fundamental in COPD assessment.

Purpose:

• To outline diagnostic criteria for COPD based on spirometry (FEV1/FVC ratio < 70%).
• To detail staging of COPD severity (Stage I-IV) using post-bronchodilator FEV1.
• To specify recommended investigations based on COPD severity.

Summary:

• Spirometry and flow-volume curves suffice for Stage I COPD.
• Stage II requires static lung volumes and bronchodilator reversibility testing.
• Stages III and IV necessitate arterial blood gases, pulse oximetry, and the 6-minute walk test (6MWT).
• The BODE index incorporates FEV1, 6MWT, dyspnea, and BMI for comprehensive assessment.
• CO transfer capacity and cardiopulmonary exercise testing are recommended for specific patient groups.

Impact:

• Establishes a clear diagnostic and staging pathway for COPD.
• Guides clinicians in selecting appropriate investigations for COPD patients.
• Promotes a multi-faceted approach to COPD assessment beyond FEV1 alone.